Oppenheimer Asset Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,083
Closed -$268K 1346
2020
Q1
$268K Buy
6,083
+709
+13% +$27.7K 0.01% 895
2019
Q4
$193K Buy
5,374
+1,515
+39% +$56.3K ﹤0.01% 1069
2019
Q3
$135K Buy
3,859
+374
+11% +$14.4K ﹤0.01% 1126
2019
Q2
$150K Buy
3,485
+85
+3% +$3.52K ﹤0.01% 1120
2019
Q1
$146K Buy
3,400
+176
+5% +$7.08K ﹤0.01% 1120
2018
Q4
$118K Buy
+3,224
New +$120K ﹤0.01% 1148
2017
Q4
Sell
-3,320
Closed -$111K 1392
2017
Q3
$111K Sell
3,320
-415
-11% -$14.3K ﹤0.01% 1179
2017
Q2
$133K Buy
3,735
+18
+0.5% +$608 ﹤0.01% 1129
2017
Q1
$114K Buy
+3,717
New +$115K ﹤0.01% 1161

Other funds holding QGEN

Oppenheimer Asset Management's QGEN Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Qiagen (QGEN) in Q2 2020, closing a stake of 6,083 shares — an estimated $268K sold.

Oppenheimer Asset Management first reported a position in QGEN in Q1 2017 and held it in 9 quarters. The position peaked at $268K in Q1 2020. 275 funds tracked by Wall St. Rank hold QGEN as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining Qiagen position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 6,083 Qiagen shares in Q2 2020, an estimated $268K.
  • Oppenheimer Asset Management first reported a position in Qiagen in Q1 2017 and held it in 9 quarters.
  • Oppenheimer Asset Management's Qiagen position peaked at $268K in Q1 2020.
  • 275 funds tracked by Wall St. Rank held Qiagen as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.